S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom

Longeveron (LGVN) News Today

$2.09
-1.44 (-40.79%)
(As of 04/17/2024 ET)
SourceHeadline
globenewswire.com logoLongeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
globenewswire.com - April 17 at 8:00 AM
msn.com logoLongeveron stock rallies 85% on Alzheimer's presentation (update)
msn.com - April 15 at 1:38 PM
msn.com logoWhat's Going On With Longeveron Stock?
msn.com - April 15 at 1:38 PM
markets.businessinsider.com logoWhy Is Longeveron (LGVN) Stock Up 48% Today?
markets.businessinsider.com - April 15 at 8:38 AM
finance.yahoo.com logoLongeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
finance.yahoo.com - April 15 at 8:38 AM
globenewswire.com logoLongeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer's Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer's Association International Conference (AAIC)
globenewswire.com - April 15 at 8:30 AM
investorplace.com logoWhy Is Longeveron (LGVN) Stock Up 48% Today?
investorplace.com - April 15 at 8:24 AM
MarketBeat logoLongeveron Inc. (NASDAQ:LGVN) CEO Mohamed Wa'el Ahmed Hashad Buys 10,638 Shares
americanbankingnews.com - April 14 at 6:18 AM
MarketBeat logoLongeveron Inc. (NASDAQ:LGVN) Director Buys $75,000.25 in Stock
americanbankingnews.com - April 14 at 5:42 AM
MarketBeat logoLongeveron Inc. (NASDAQ:LGVN) Insider Purchases $250,000.05 in Stock
americanbankingnews.com - April 14 at 4:42 AM
finance.yahoo.com logoChief Scientific Officer Joshua Hare Acquires 148,936 Shares of Longeveron Inc (LGVN)
finance.yahoo.com - April 13 at 8:35 AM
insidertrades.com logoMohamed Wa'el Ahmed Hashad Acquires 10,638 Shares of Longeveron Inc. (NASDAQ:LGVN) Stock
insidertrades.com - April 13 at 7:22 AM
globenewswire.com logoLongeveron Announces Closing of $5.2 Million Public Offering
globenewswire.com - April 11 at 5:17 PM
globenewswire.com logoLongeveron Announces Pricing of $5.25 Million Public Offering
globenewswire.com - April 8 at 2:15 PM
globenewswire.com logoLongeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals
globenewswire.com - April 8 at 8:30 AM
investorplace.com logoWhy Is Longeveron (LGVN) Stock Up 82% Today?
investorplace.com - April 8 at 7:56 AM
marketbeat.com logoLongeveron Inc. (NASDAQ:LGVN) Sees Large Decline in Short Interest
marketbeat.com - March 27 at 10:35 PM
marketbeat.com logo
marketbeat.com - March 27 at 6:06 AM
globenewswire.com logoLongeveron Announces 1-for-10 Reverse Stock Split
globenewswire.com - March 19 at 4:01 PM
finance.yahoo.com logoLongeveron Full Year 2023 Earnings: EPS Misses Expectations
finance.yahoo.com - March 1 at 7:40 AM
seekingalpha.com logoLongeveron Inc. (LGVN) Q4 2023 Earnings Call Transcript
seekingalpha.com - February 29 at 4:23 PM
investing.com logoLongeveron LLC earnings missed by $0.81, revenue topped estimates
investing.com - February 29 at 4:23 PM
finance.yahoo.com logoLongeveron Inc. (NASDAQ:LGVN) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 28 at 10:14 AM
benzinga.com logoRecap: Longeveron Q4 Earnings
benzinga.com - February 27 at 6:56 PM
globenewswire.com logoLongeveron Reports Year-End 2023 Results and Provides Corporate Update
globenewswire.com - February 27 at 4:05 PM
benzinga.com logoLongeveron Stock (NASDAQ:LGVN) Dividends: History, Yield and Dates
benzinga.com - February 22 at 6:38 AM
finance.yahoo.com logoLongeveron to Report Year-End 2023 Results and Provide Corporate Update February 27, 2024
finance.yahoo.com - February 21 at 5:44 PM
globenewswire.com logoLongeveron to Report Year-End 2023 Results and Provide Corporate Update February 27, 2024
globenewswire.com - February 21 at 4:05 PM
markets.businessinsider.com logoBuy Rating Affirmed: Longeveron’s Intellectual Property and Pipeline Progress Signal Market Growth
markets.businessinsider.com - January 30 at 11:46 AM
theglobeandmail.com logoLongeveron (NASDAQ: LGVN) Granted US Patent Allowance for Key Tech Behind Lead Investigation Product
theglobeandmail.com - January 30 at 11:46 AM
marketwatch.com logoLongeveron Shares Hit 52-Week Low After Direct Offering Prices
marketwatch.com - December 21 at 1:17 PM
msn.com logoWhy Longeveron (LGVN) Shares Are Falling Sharply
msn.com - December 21 at 1:17 PM
finance.yahoo.com logoUPDATE -- Longeveron Announces $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
finance.yahoo.com - December 21 at 1:17 PM
finance.yahoo.com logoLongeveron Announces $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
finance.yahoo.com - December 21 at 8:16 AM
msn.com logoHC Wainwright & Co. Initiates Coverage of Longeveron Inc - (LGVN) with Buy Recommendation
msn.com - December 4 at 5:35 PM
benzinga.com logoLong-term Survival Data from Longeveron's ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart Association
benzinga.com - November 11 at 9:59 AM
finance.yahoo.com logoLongeveron Inc. (NASDAQ:LGVN) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 11 at 9:59 AM
finance.yahoo.com logoLong-term Survival Data from Longeveron’s ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart Association
finance.yahoo.com - November 11 at 9:59 AM
msn.com logoLGVN Continues to Show Progress
msn.com - November 10 at 1:52 PM
finance.yahoo.com logoLongeveron Reports Third Quarter 2023 Results and Provides Corporate Update
finance.yahoo.com - November 10 at 8:52 AM
finance.yahoo.com logoLongeveron to Report Third Quarter 2023 Results and Provide Corporate Update on November 10, 2023
finance.yahoo.com - November 3 at 10:42 AM
finance.yahoo.com logoLongeveron Inc. Featured in Syndicated Broadcast Highlighting Top-Line Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ for the Treatment of Mild Alzheimer’s
finance.yahoo.com - October 24 at 8:48 AM
benzinga.com logoNearly A Third Of Japan's 36 Million Seniors Are At Risk Of Aging Frailty – Could Lomecel-BTM, Longeveron's (NASDAQ: LGVN) Cell Therapy Help?
benzinga.com - October 23 at 12:21 PM
finance.yahoo.com logoLongeveron Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
finance.yahoo.com - October 12 at 9:32 AM
finance.yahoo.com logoLGVN Announces Positive Alzheimer’s Test Results
finance.yahoo.com - October 5 at 7:18 PM
benzinga.com logoLongeveron Announces Positive Top-Line Results For Lomecel-BTM In Its CLEAR MIND Phase 2a Clinical Trial In The Treatment Of Mild Alzheimer's Disease
benzinga.com - October 5 at 2:18 PM
markets.businessinsider.com logoLongeveron: Phase 2a Trial Validate Safety, Therapeutic Potential Of Lomecel-B In Mild Alzheimer's
markets.businessinsider.com - October 5 at 9:17 AM
msn.com logoLongeveron stock jumps on Alzheimer’s trial results
msn.com - October 5 at 9:17 AM
theglobeandmail.com logoLongeveron (NASDAQ: LGVN) to Discuss Cellular Therapy Programs at H.C. Wainwright Conference
theglobeandmail.com - September 15 at 9:35 AM
benzinga.com logoLongeveron Issues Letter To Stockholders
benzinga.com - September 11 at 4:20 PM
Get Longeveron News Delivered to You Automatically

Sign up to receive the latest news and ratings for LGVN and its competitors with MarketBeat's FREE daily newsletter.

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

LGVN Media Mentions By Week

LGVN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LGVN
News Sentiment

0.55

0.44

Average
Medical
News Sentiment

LGVN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LGVN Articles
This Week

16

1

LGVN Articles
Average Week

Get Longeveron News Delivered to You Automatically

Sign up to receive the latest news and ratings for LGVN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:LGVN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners